Brought to you by 
The Medicines Co. buys Curacyte division for €14.5mm
Aug 2008
Executive Summary
The Medicines Co. (critical care therapeutics) paid €14.5mm ($22.6mm) to buy Curacyte Discovery GMBH, a division of acute care drug company Curacyte AG that focuses on blood conditions.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Includes Earnout
- Intra-Biotech Deal
- Includes Contract
- Acquisition of Private Biotech
- Full Acquisition
- Payment Includes Cash
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
The Medicines Co. buys Curacyte division for €14.5mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice